SWEET TASTE RECEPTOR ANTAGONIST COMPOSITIONS
The present disclosure relates to compositions comprising gymnemic acid, together with a form of zinc to block the unpleasant bitter taste of gymnemic acid as well as to extend the sweet taste blocking properties of gymnemic acid, resulting in palatable compositions for delivery to the oral cavity to block sweet taste receptors located therein. The present disclosure also relates to methods of reducing sugar consumption and reducing calorie intake via administration of such compositions to a subject.
1 . A composition comprising gymnemic acid and at least one form of zinc.
2 . The composition of claim 1 , wherein the delivery form is selected from the group consisting of a lozenge, an orally disintegrating tablet, an orally dispersible tablet, a troche, a hard candy, a soft candy, a jelly, a gum, an edible film, an orally dissolvable film, a wafer, a drop, an oral spray, a liquid, a powder and combinations thereof.
3 . The composition of claim 2 , wherein the delivery form is an orally disintegrating tablet having a disintegration time in the range of from about 30 seconds to about 5 minutes.
4 . The composition of claim 1 , wherein the form of zinc is selected from the group consisting of zinc acetate, zinc carbonate, zinc chloride, zinc citrate, zinc gluconate, zinc sulfate, zinc hydrosulfite, zinc bisulfite, zinc oxide, zinc halide, zinc hydride, zinc carbide, and combinations thereof.
5 . The composition of claim 1 , wherein the form of zinc is zinc gluconate.
6 . The composition of claim 1 , wherein the gymnemic acid is selected from the group consisting of an inorganic salt of gymnemic acid, an organic salt of gymnemic acid, a cyclodextrin complex of gymnemic acid, a cryptand complex of gymnemic acid, a hydrate of gymnemic acid, a solvate of gymnemic acid, and combinations thereof.
7 . The composition of claim 5 , wherein the solvate of gymnemic acid is selected from the group consisting of ethanol solvates of gymnemic acid and combinations thereof.
8 . The composition of claim 1 , wherein the delivery form may further comprise mint.
9 . The composition of claim 1 , wherein the delivery form may further comprise a bitter taste inhibitor is selected from the group consisting of a sodium salt, a lipoprotein, and combinations thereof.
10 . The composition of claim 1 , further comprising at least one sour taste inhibitor.
11 . The composition of claim 8 , wherein the at least one sour taste inhibitor is miraculin.
12 . A lingual delivery form comprising the composition of claim 1 .
13 . The lingual delivery form of claim 12 , wherein the delivery form is selected from the group consisting of a lozenge, an orally disintegrating tablet, an orally dispersible tablet, a troche, a hard candy, a soft candy, a jelly, a gum, an edible film, an orally dissolvable film, a wafer, a drop, an oral spray, a liquid, a powder and combinations thereof.
14 . The lingual delivery form of claim 13 , wherein the delivery form is an orally disintegrating tablet having a disintegration time in the range of from about 30 seconds to about 5 minutes.
15 . The lingual delivery form of claim 12 , wherein the form of zinc is selected from the group consisting of zinc acetate, zinc carbonate, zinc chloride, zinc citrate, zinc gluconate, zinc sulfate, zinc hydrosulfite, zinc bisulfite, zinc oxide, zinc halide, zinc hydride, zinc carbide, and combinations thereof.
16 . The composition of claim 12 , wherein the form of zinc is zinc gluconate.
17 . The composition of claim 12 , wherein the gymnemic acid is selected from the group consisting of an inorganic salt of gymnemic acid, an organic salt of gymnemic acid, a cyclodextrin complex of gymnemic acid, a cryptand complex of gymnemic acid, a hydrate of gymnemic acid, a solvate of gymnemic acid, and combinations thereof.
18 . The composition of claim 17 , wherein the solvate of gymnemic acid is selected from the group consisting of ethanol solvates of gymnemic acid and combinations thereof.
19 . The composition of claim 12 , wherein the delivery form may further comprise mint.
20 . The composition of claim 12 , wherein the delivery form may further comprise a bitter taste inhibitor is selected from the group consisting of a sodium salt, a lipoprotein, and combinations thereof.
21 . The composition of claim 12 , further comprising at least one sour taste inhibitor.
22 . The composition of claim 21 , wherein the at least one sour taste inhibitor is miraculin.
23 . A method of reducing sugar consumption, comprising administering the composition of claim 1 to a subject.
24 . A method of reducing calorie intake, comprising administering the composition of claim 1 to a subject.
25 . A method of reducing dental caries, comprising administering the composition of claim 1 to a subject.